HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akihiro Takahashi Selected Research

Akihiro Takahashi Research Topics

Disease

13Neoplasms (Cancer)
05/2018 - 01/2002
13Stomach Neoplasms (Stomach Cancer)
09/2006 - 01/2002
3Gastroesophageal Reflux (GERD)
09/2018 - 09/2005
3Neoplasm Metastasis (Metastasis)
01/2003 - 01/2002
2Headache (Headaches)
06/2022 - 12/2020
2Fibrosis (Cirrhosis)
10/2017 - 07/2017
2Aneurysm (Aneurysms)
06/2014 - 09/2006
2Alzheimer Disease (Alzheimer's Disease)
02/2007 - 12/2005
2Duodenogastric Reflux
06/2006 - 09/2005
2Peptic Esophagitis (Reflux Esophagitis)
06/2006 - 09/2005
2Inflammation (Inflammations)
04/2006 - 06/2005
2Atherosclerosis
06/2005 - 12/2003
2Carcinoma (Carcinomatosis)
06/2004 - 01/2002
1Diplopia (Double Vision)
06/2022
1Myasthenia Gravis
06/2022
1Non-Erosive Reflux Disease
09/2018
1Colonic Neoplasms (Colon Cancer)
10/2017
1Hemorrhage
07/2017
1Bradycardia
07/2017
1Genomic Instability
01/2016
1Retinal Vasculitis
01/2015
1White Dot Syndromes
01/2015
1Apical Hypertrophic Cardiomyopathy
06/2014
1Constipation
01/2011
1Chronic Obstructive Pulmonary Disease (COPD)
01/2011
1Hypothyroidism
01/2011
1Liver Diseases (Liver Disease)
07/2007
1Ischemic Stroke
02/2007
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
02/2007
1Stroke (Strokes)
02/2007
1Dementia (Dementias)
02/2007
1Esophageal Neoplasms (Esophageal Cancer)
09/2006
1Rupture
09/2006
1Ruptured Aneurysm
09/2006
1Atherosclerotic Plaque (Atheroma)
08/2006
1Esophagitis
06/2006
1Cognitive Dysfunction
12/2005
1Oculocerebrorenal Syndrome (Lowe Syndrome)
08/2005

Drug/Important Bio-Agent (IBA)

6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2007 - 01/2002
4Peptides (Polypeptides)IBA
11/2006 - 03/2002
4CytokinesIBA
06/2005 - 04/2003
3Chylomicron RemnantsIBA
08/2006 - 12/2003
3AntigensIBA
04/2004 - 03/2002
3Oxygen (Dioxygen)IBA
02/2004 - 04/2003
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2004 - 01/2002
2Proton Pump InhibitorsIBA
09/2018 - 01/2011
2Hypnotics and Sedatives (Sedatives)IBA
07/2017 - 01/2011
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2007 - 12/2005
2EpitopesIBA
11/2006 - 04/2004
2TrypsinIBA
06/2006 - 09/2005
2Lipoproteins (Lipoprotein)IBA
06/2005 - 12/2003
2Trastuzumab (Herceptin)FDA Link
04/2004 - 10/2002
2Messenger RNA (mRNA)IBA
01/2004 - 01/2002
2Proteins (Proteins, Gene)FDA Link
01/2004 - 01/2002
2Vascular Endothelial Growth Factor CIBA
01/2003 - 01/2002
2HLA-A2 Antigen (HLA A2 Antigen)IBA
11/2002 - 03/2002
2Proliferating Cell Nuclear Antigen (PCNA)IBA
08/2002 - 01/2002
1Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric
06/2022
11- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
09/2018
1Protons (Proton)IBA
09/2018
1NanogelsIBA
05/2018
1Drug CarriersIBA
05/2018
1chinese inkIBA
10/2017
1Pharmaceutical PreparationsIBA
07/2017
1Ribosomal DNA (rDNA)IBA
01/2016
1Retinaldehyde (Retinal)IBA
01/2015
1Verapamil (Calan)FDA LinkGeneric
06/2014
1Vasodilator Agents (Vasodilators)IBA
01/2011
1DiureticsIBA
01/2011
1Antidepressive Agents (Antidepressants)IBA
01/2011
1Anti-Anxiety Agents (Anxiolytics)IBA
01/2011
1Thyroid HormonesIBA
01/2011
1HDL CholesterolIBA
07/2007
1LDL CholesterolIBA
07/2007
1Amyloid (Amyloid Fibrils)IBA
02/2007
1CholesterolIBA
02/2007
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2007
1HLA-A24 AntigenIBA
11/2006
1vasectrin IIIIBA
09/2006
1FibrinIBA
09/2006
1Hemostatics (Antihemorrhagics)IBA
09/2006
1Glycoproteins (Glycoprotein)IBA
08/2006
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
08/2006
1Bile Acids and Salts (Bile Acids)IBA
06/2006
1Apolipoproteins E (ApoE)IBA
04/2006
1Simvastatin (Zocor)FDA LinkGeneric
12/2005
1Atorvastatin (Lipitor)FDA Link
12/2005
1camostatIBA
09/2005
1Trypsin InhibitorsIBA
09/2005
1LipidsIBA
08/2005

Therapy/Procedure

8Therapeutics
06/2022 - 01/2002
3Drug Therapy (Chemotherapy)
05/2018 - 01/2002
3Gastrectomy
06/2006 - 02/2003
2Epidural Blood Patch
06/2022 - 12/2020
2Gastroenterostomy
06/2006 - 09/2005
1Tattooing
10/2017
1Investigational Therapies (Experimental Therapy)
02/2007
1Craniotomy
09/2006
1Oral Administration
09/2005
1Aftercare (After-Treatment)
09/2005